Irish Pharma start-up raises €750,000

Irish pharmaceutical start-up Inflection Biosciences has raised €750,000 from private investors as it moves forward with the pre-clinical development of a cutting edge cancer treatment.

8th March, 2015
Irish Pharma start-up raises €750,000
Darren Cunningham, chief executive, and Dr Michael O’Neill, research and design director, Inflection BiosciencesBarry Cronin

The funding deal is the Dublin-based company’s second to date, bringing its total funding to €1.2 million.

The company also recently agreed a separate funding collaboration with the Multiple Myeloma Research Foundation in the United States, one of the world’s leading private funders of research into multiple myeloma – a type of cancer which begins in bone marrow plasma cells.

Inflection Biosciences has signed a licence agreement with the Spanish National...

Subscribe from just €1 for the first month!


What's Included

With any subscription you will have access to

  • 971569B3-2C5E-4C45-B798-CEADE16987A8

    Unlimited multi-device access to our iPad, iPhone and Android Apps

  • 099C8662-C57C-42F2-9426-F2F90DF17C8F

    Unlimited access to our eReader library

  • 198AE43B-B9CF-4892-8769-D63C2104BA08

    Exclusive daily insight and opinion seven days a week

  • D8F37B78-25E4-4E4A-A376-4F5789B1564A

    Create alerts to never miss a subject that matters to you

  • B15F2521-37CD-4E02-B898-730A20D39F7F

    Get access to exclusive offers for subscribers on gifts and experiences

  • A564FE02-1AB8-4579-AF9D-BA32A2E5ACA7

    Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine

Share this post

Related Stories

Content is king – just ask Netflix as rivals attempt to steal its crown

Tom Maguire: Tax changes we make now could help business for years